MedTrace Logo

Effect of Intravenous Metoprolol Combining RIC on Myocardial Protection in STEMI Patients

NCT03579914 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1206

Last updated 2021-11-04

No results posted yet for this study

Summary

The main purpose of this study is to compare the myocardial protection effect of intravenous metoprolol combined with remote ischemic conditioning (RIC) and single treatment before reperfusion in Chinese patients with anterior STEMI. This study sought to find possible strategies to further improve myocardial protection in Chinese patients with anterior STEMI.

Conditions

Interventions

DRUG

intravenous Placebo

Patients receive intravenous Placebo (saline) injection

DRUG

Metoprolol Injectable Product

Patients receive intravenous Metoprolol injection

DEVICE

Romote Ischemic Conditioning (RIC)

Patients receive RIC treatment

COMBINATION_PRODUCT

Metoprolol & RIC

Patients receive Metoprolol \& RIC treatment

Sponsors & Collaborators

  • Beijing Chao Yang Hospital

    collaborator OTHER

  • Harbin Medical University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-11-28
Primary Completion
2020-08-31
Completion
2021-08-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03579914 on ClinicalTrials.gov